New directors for ARCS Australia with the addition of former CEO Marisa Peterson and the founder and managing director of Commercial Eyes, Andrew Carter.
President and Board chair George Papadopoulos announced the new directors at yesterday's annual general meeting.
Current director Robert Kent, Research Operations Manager at The Kinghorn Cancer Centre, was re-elected for another three-year term.
Ms Peterson was most recently the CEO of George Clinical and led ARCS from 2005 to 2010.
Mr Carter is well-known across the sector and brings three decades experiences in the medicines and medical device industry to the ARCS board.
“I welcome the new and returning Board Directors and look forward to working with each one to shape the future of the organisation,” said Mr Papadopoulos.
“It was outstanding to see 11 ARCS members nominate for three Board Director positions. It’s a testament to the work of the previous Board Directors and the ARCS office, that we had such a great response to the nomination process. Congratulations to the incoming Board Directors."
He continued, “I’d like to thank retiring Board Director and Vice-President, Kaylene O’Shea, who was first appointed in November 2014 and has contributed substantially to the strategic direction of ARCS in that time; as well as thanking Jessica Keast, who has been a Board Director since November 2016 and has equally contributed to ARCS strategic direction.
"Lastly, I would like to thank Naomi Beveridge, who stepped down as Independent Director prior to the AGM. It has been a privilege and a pleasure working with Kaylene, Jessica and Naomi over the past years and I would like to thank them again for their contributions to ARCS and the healthcare sector.”